The Society for Immunotherapy of Cancer (SITC) is pleased to announce a new corporate membership program. Designed to foster communication between industry partners and SITC leaders, organizations from all touchpoints within industry, including pharmaceutical, technology and investments firms, will be eligible for a SITC corporate membership.
A SITC corporate membership will provide organizations in the field of cancer immunotherapy and cancer research a forum in which to address common issues impacting the field with the goal of improving cancer patient outcomes.
Benefits of the SITC corporate membership program include:
Dues for SITC corporate memberships will be determined by the size of the organization. The dues structure is as follows:
SITC is proud to be a broker of new relationships among the individuals leading the next generation of cancer immunotherapy research.
To learn more about how your organization can benefit from becoming a SITC member, call (414) 271-2456 or email NNikolic@sitcancer.org.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com